Acute myeloid leukemia (AML) is an aggressive form of blood cancer that causes the uncontrolled growth of abnormal myeloid cells. It predominantly affects the bone marrow and blood, but cancer cells can sometimes infiltrate the central nervous system (CNS), leading to AML in spinal fluid.

Doctors associate CNS involvement with an increased risk of disease relapse and poorer outcomes. However, treatments are improving, and as a result, so too is the overall survival rate.

Myeloid cells are blood cells involved in immunity against infections. They originate in the bone marrow and differentiate into various types, including granulocytes, monocytes, macrophages, dendritic cells, and platelets.

Doctors typically diagnose AML in people aged 65 and over. However, CNS involvement is more common in children with the disease.

This article examines the challenges of AML in spinal fluid, symptoms, treatment, and outlook.

there is a black and white photo of a person with a red marker showing the top of their spineShare on Pinterest
James Darell/Getty Images

AML can enter the spinal fluid of adults and children with the condition, but it is rare. Some studies suggest that CNS involvement occurs in 0.6% of adults with AML at initial presentation and 2.9% of relapse cases. However, in infants, this figure increases to 29% of cases.

CNS involvement is more common with acute lymphoblastic leukemia, affecting around 5% of cases.

While AML primarily affects the bone marrow and blood cells, only a small percentage of individuals with AML develop CNS involvement.

If doctors suspect CNS involvement, they can take a sample of cerebrospinal fluid to confirm. A person with AML in the CNS may also have tumors in the cerebrum in the brain or the membrane (meninges) protecting the brain and spinal cord.

When AML is in spinal fluid, it means leukemia cells have spread beyond the bone marrow and blood circulation. As a result, it suggests a higher disease burden, an increased relapse risk, and worse outcomes.

Read about testing and staging of AML.

If a person has AML in spinal fluid, treatments can include:

Learn more about treatment for AML.

Because AML in spinal fluid is a serious complication, adult survival rates are lower than AML without CNS involvement or other blood cancers. However, survival rates for leukemia, in general, have improved dramatically in recent decades.

For AML, the 5-year survival rate is almost 30% overall and 70.6% for those under 15.

The survival rate refers to the proportion of people who are still alive for a length of time after receiving a particular diagnosis. For example, a 5-year survival rate of 50% means that 50%, or half, of the people are still alive 5 years after receiving the diagnosis.

It is important to remember that these figures are estimates and are based on the results of previous studies or treatments. A person can consult a healthcare professional about how their condition is going to affect them.

Was this helpful?

Individuals facing a diagnosis of AML in spinal fluid or CNS involvement often have questions and concerns that require expert guidance. When consulting a doctor, here are some questions that can serve as a starting point for discussions:

  • What diagnostic tests are necessary to confirm AML in spinal fluid?
  • What are the treatments for AML in the spine, and which approach is most suitable for my specific case?
  • What potential side effects or complications should I expect during and after treatment?
  • How will AML involvement in the spine impact my overall outlook and long-term outcomes?
  • Are there any clinical trials or experimental treatments available for AML in the spine that I should consider?
  • How can I access additional resources or support groups to connect with others facing similar challenges?

AML in spinal fluid, though rare, is a severe complication. It can affect the severity of the disease, outcomes, and life expectancy.

A person may experience no symptoms when AML is in the spinal fluid. However, headaches, balance and vision issues, and nausea can occur.

It is crucial for individuals with AML in the spinal fluid to collaborate closely with their healthcare team. By seeking expert guidance, people can make informed decisions about their treatment options and enhance their overall outlook.

While AML in spinal fluid may present unique obstacles, it is important to remain hopeful and resilient. Advances in diagnostic techniques and treatments continue to improve outcomes.